| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/04/2010 | CA2726234A1 Antihistamine and antihistamine-like nasal application, products, and method |
| 03/03/2010 | EP2159230A1 Anti-TNF antibodies, compositions, methods and uses |
| 03/03/2010 | EP2159226A1 Antihistaminic and antiallergic agent and a method for the production thereof. |
| 03/03/2010 | EP2158213A1 Vm23 and vm24, two scorpion peptides that block human t-lymphocyte potassium channels (sub-type kv1.3) with high selectivity and decrease the in vivo dth-responses in rats |
| 03/03/2010 | EP1743648B1 Method for treating inflammation |
| 03/03/2010 | EP1651266B1 Administration of anti-tnf-alpha f(ab')2 antibody fragments |
| 03/03/2010 | EP1569656B1 Phosphoantigens for regulating an immune response |
| 03/03/2010 | EP1505973B1 Combinations for treating multiple myeloma |
| 03/03/2010 | EP1496920B1 Pharmaceutical composition containing an extract from barleria prionitis linn and its process of preparation |
| 03/03/2010 | EP1162998B1 Vaccine against streptococcus pneumoniae capsular polysaccharides |
| 03/03/2010 | EP1100801B1 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein |
| 03/02/2010 | US7671250 Mammal that has acquired immunological tolerance to a foreign DNA and/or its expression product; expresses a fetal immature T lymphocyte transfected with the foreign DNA into a thymus that has been radiated to transiently suppress T lymphocytes |
| 03/02/2010 | US7671186 Multimeric hybrid genes encoding the chimeric protein; single recombinant immunogen capable of protecting infants and similar susceptible individuals against diseases caused by both parainfluenza virus (PIV) and respiratory syncytial virus (RSV) |
| 03/02/2010 | US7671180 Heparin binding protein for use in diagnosis, prvention and treatment of cell proliferative, liver, neurodegeneartive, inflammatory and pancreatic disorders; wound healing agents |
| 03/02/2010 | US7671177 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders |
| 03/02/2010 | US7671090 Inhibitors of α4 mediated cell adhesion |
| 03/02/2010 | US7671087 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 03/02/2010 | US7671078 1,3-dicyclohexyl-2-(5,6-dihydro-imidazo[2,1-b]thiazol-3-ylmethyl)-isothiourea; 1,3-dicycloheptyl-2-(6,6-dimethyl-5,6-dihydroimidazo[2,1-b]thiazol-3-ylmethyl)-isothiourea; CXC chemokine Receptor |
| 03/02/2010 | US7671071 Crystal structure; antihistamines; histamine H1-antagonists; side effect reduction; storage stability |
| 03/02/2010 | US7670829 from a simple carbon source; includes 17 alpha -hydroxypregnenolone, cortisol, cortexolone, 17 alpha -hydroxyprogesterone, and derivatives; genetic engineering |
| 03/02/2010 | US7670618 Pharmaceutical compositions |
| 03/02/2010 | US7670600 increased in vivo half-lives due to the presence of an immunoglobulin G (IgG) constant domain; pharmacokinetics; diagnosis or immunotherapy; antibody conjugates; palivizumab |
| 03/02/2010 | CA2394615C Substituted 1,3,4-oxadiazoles and a method of reducing tnf-.alpha. levels |
| 02/25/2010 | WO2010022358A1 6-substituted 2-(benzimidazolyl)purine and purinone derivatives and 6-substituted 2-(imidazoio[4,5- c]pyridinyl)purine and purinone derivatives for immunosuppression |
| 02/25/2010 | WO2010022217A1 Combinations comprising bicyclic s1p lyase inhibitors |
| 02/25/2010 | WO2010021697A2 Antibodies to ccr2 |
| 02/25/2010 | WO2010020981A1 A3 adenosine receptor allosteric modulators |
| 02/25/2010 | WO2010020905A1 Pyrrolo[2,3-d]pyrimidine compounds |
| 02/25/2010 | WO2010020593A1 Treatment of an autoimmune disease using il-18 antagonists |
| 02/25/2010 | WO2010020057A1 Treatment and/or Prevention of Peanut Induced Anaphylaxis |
| 02/25/2010 | WO2009158571A8 Heteroaryl compounds and uses thereof |
| 02/25/2010 | WO2009143816A4 Method for isolating cells and disease vectors from bodily fluids |
| 02/25/2010 | WO2009140236A3 Staphylococcus aureus-specific antibody preparations |
| 02/25/2010 | WO2009138494A3 Amino acid sequences directed against toll-like receptors and their use for the treatment of diseases related to toll-like receptors |
| 02/25/2010 | WO2009106752A3 Derivatives of 2-heteroaroyl-imidazol[1,2-a]pyridine, preparation thereof and therapeutic application thereof |
| 02/25/2010 | US20100048698 Macrocyclic diterpenes for treating conditions associated with protein kinase c |
| 02/25/2010 | US20100048680 Alpha-1-Antitrypsin Variants and Uses Thereof |
| 02/25/2010 | US20100048679 Polynucleotide therapy |
| 02/25/2010 | US20100048639 Oxadiazole derivates as s1p1 receptor agonists |
| 02/25/2010 | US20100048588 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 02/25/2010 | US20100048586 Multifunctional bioactive compounds |
| 02/25/2010 | US20100048568 Pyrimidine hydrazide compounds as pgds inhibitors |
| 02/25/2010 | US20100048565 Benzimidazole derivatives |
| 02/25/2010 | US20100048558 Thienopyridines |
| 02/25/2010 | US20100048557 Triazolopyridine JAK Inhibitor Compounds and Methods |
| 02/25/2010 | US20100048547 Pi 3-kinase inhibitors and methods of their use |
| 02/25/2010 | US20100048539 Compounds and compositions as protein kinase inhibitors |
| 02/25/2010 | US20100048495 Core 2 GlcNAc-T inhibitors III |
| 02/25/2010 | US20100048488 Immunomodulatory peptides |
| 02/25/2010 | US20100048486 Use of Soluble Fgl2 As An Immunosuppressant |
| 02/25/2010 | US20100048470 Immunotoxins for the treatment of diseases related to cmv infection |
| 02/25/2010 | US20100048465 Peptide mimics of melanocyte stimulating hormone |
| 02/25/2010 | US20100047896 Nucleic acid construct containing full length genome of human hepatitis C virus, recombinant full length virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus particle |
| 02/25/2010 | US20100047339 Compositions for the treatment of chronic degenerative inflammatory conditions |
| 02/25/2010 | US20100047333 Modified Peptides and Their Use for the Treatment of Autoimmune Diseases |
| 02/25/2010 | US20100047327 Adjuvant for Transdermal or Transmucosal Administration and Pharmaceutical Preparation Containing the Same |
| 02/25/2010 | US20100047307 Injectable drug carrier comprising layered double hydroxide |
| 02/25/2010 | US20100047289 Universal tumor cell vaccine for anti cancer therapeutic and prophylactic utilization |
| 02/25/2010 | US20100047288 Hybrid cells for treating cancer patients |
| 02/25/2010 | US20100047287 Outer membrane vesicles and uses thereof |
| 02/25/2010 | US20100047275 Peptide sequences and compositions |
| 02/25/2010 | US20100047273 Coxsackie B virus and type 1 diabetes |
| 02/25/2010 | US20100047271 Vaccine compositions |
| 02/25/2010 | US20100047268 Fusion proteins of hiv regulatory/accessory proteins |
| 02/25/2010 | US20100047262 Novel method for down-regulation of amyloid |
| 02/25/2010 | US20100047260 Methods and Compositions Relating To a Vaccine Against Prostate Cancer |
| 02/25/2010 | US20100047258 Drug Carriers, Their Synthesis, and Methods of Use Thereof |
| 02/25/2010 | US20100047250 Activation epitope of fcy rii (cd32), binding molecules that specifically bind the epitope and means and methods for the detection of the epitope, and uses of said epitope or said binding molecules |
| 02/25/2010 | US20100047245 Complementary determining regions (CDR); interleukins (IL-12) |
| 02/25/2010 | US20100047220 Substances |
| 02/25/2010 | US20100047215 Stem cell targeting methods |
| 02/25/2010 | US20100047208 Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor gm-csf in tumor cells and uses thereof |
| 02/25/2010 | US20100047204 Use of organic compounds |
| 02/25/2010 | US20100047168 Soluble Zcytor 11 Cytokine Receptors |
| 02/25/2010 | DE102008002999A1 Composition, useful as anticancer or immunostimulants, cosmetics, preferably hair growth- and/or nail care products, dietary supplement and all-purpose cleaners and to treat e.g. gastric ulcers and cold, comprises ginger and chamomile |
| 02/25/2010 | CA2735048A1 6-substituted 2-(benzimidazolyl)purine and purinone derivatives and 6-substituted 2-(imidazolo[4,5- c]pyridinyl)purine and purinone derivatives for immunosuppression |
| 02/25/2010 | CA2734755A1 Treatment and/or prevention of peanut induced anaphylaxis |
| 02/25/2010 | CA2734655A1 Combinations comprising bicyclic s1p lyase inhibitors |
| 02/25/2010 | CA2734645A1 Engineered anti-il-13 antibodies, compositions, methods and uses |
| 02/25/2010 | CA2734578A1 Antibodies to ccr2 |
| 02/25/2010 | CA2734358A1 Treatment of an autoimmune disease using il-18 antagonists |
| 02/25/2010 | CA2734265A1 Dock-and-lock (dnl) vaccines for cancer therapy |
| 02/25/2010 | CA2733514A1 Formulation for oral administration of proteins |
| 02/25/2010 | CA2733359A1 Pyrrolo[2,3-d]pyrimidine compounds |
| 02/24/2010 | EP2157087A1 3-(4-{[4-(4-{[3-(3,3-dimethyl-1-piperidinyl)propyl]oxy}phenyl)-1-piperidinyl]carbonyl}-1-naphthalenyl)propanoic or propenoic acid as h1 and h3 receptor antagonists for the treatment of inflammatory and/or allergic disorders |
| 02/24/2010 | EP2156841A1 Conditioned blood compound and method for its manufacture |
| 02/24/2010 | EP2156840A2 Use of mometasone furoate for treating airway passage and lung diseases |
| 02/24/2010 | EP2155791A1 Humanized and chimeric anti-trop-2 antibodies that mediate cancer cell cytotoxicity |
| 02/24/2010 | EP2155743A1 Imidazoquinolines with immuno-modulating properties |
| 02/24/2010 | EP2155712A1 3-(imidazolyl)-pyrazoloý3,4-b¨pyridines |
| 02/24/2010 | EP2155202A2 3,6-disubstituted-imidazo[1,2-b]pyridazines and 3,5-disubstituted pyrazolo[1,5-a]pyrimidines as phosphatidylinositol-3-kinase inhibitors |
| 02/24/2010 | EP2155184A2 Prophylactic and therapeutic use of sirtuin inhibitors in tnf-alpha mediated pathologies |
| 02/24/2010 | EP1465631B1 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 02/24/2010 | EP1461316B1 Synthesis of 2-cyanoziridine-1-carboxamide |
| 02/24/2010 | EP0837696B1 Improved delivery of diagnostic and therapeutic agents to a target site |
| 02/24/2010 | CN101654673A Rna interference mediating small rna molecules |
| 02/24/2010 | CN101654672A Rna interference mediating small rna molecules |
| 02/24/2010 | CN101654479A Mammalian receptor proteins, agents, and methods relating thereto |
| 02/24/2010 | CN101653603A Peptides and antibodies binding to anionic phospholipids and aminophospholipids and their use in treating disease |
| 02/24/2010 | CN100591760C Process for producing cytotoxic lymphocyte |